Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Chris Learn, Ph.D., PMP, recently joined Parexel as Vice President, Head of the Cell and Gene Center of Excellence. During Chris’ first week, we asked him to share his professional experiences, his expectations for leading the Center of Excellence, and his inspiration behind his work.

Regulatory & Access Resources

Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Parexel names first Patient Ambassador

Mitigating FSP talent shortfalls through development

Adapting drug supply strategies to modern study models

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

Patients as Partners 2022: Moving from Insights to Action

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

End-to-end risk management: Getting the most from your program

Getting to ‘No’ fast is more important when you are small

Six steps to maximize inclusivity within medical communications | Part 1: Race and Ethnicity

Pragmatic Trials: Targeting evidence generation to inform market access and meet payers’ needs

Three Ways Early-Stage Companies Can Attract Investors

What's the Future of FSP?

Master Protocol Trials: What Are the Elements of Success?

CNS Summit Recap: The Future is Collaborative

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Biosimilar Development: Are therapeutic clinical trials needed?

Clinical pharmacology, modeling and simulation to support FIH study design

Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data